OSL 16.7% 0.5¢ oncosil medical ltd

Ann: Half Yearly Report and Accounts, page-57

  1. 1,445 Posts.
    lightbulb Created with Sketch. 416
    Done very little in 7 years - FACT

    well they have done one thing - notably cost shareholders a lot of money. FACT

    $93k in revenue YTD. Won’t pay the bills so we shareholders are still left paying the bills. FACT

    $800k per year - just the costs to run an ASX listing with regulatory and administration expenses.FACT

    Potential - jury is out for me. Cannot see compelling numbers next 12 months. OVERVALUED

    IMO slow sales will continue. There is no evidence to the contrary.

    As a long term investor with 7 figures invested in the market realism beats optimism.





 
watchlist Created with Sketch. Add OSL (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(16.7%)
Mkt cap ! $16.66M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $2.867K 573.4K

Buyers (Bids)

No. Vol. Price($)
8 4186862 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 15328756 23
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.